Status:

COMPLETED

Effects of a Probiotic Supplementation on Symptoms and Microbiome Characteristics in Patients With Non-celiac Gluten/Wheat Sensitivity.

Lead Sponsor:

University of Turin, Italy

Conditions:

Gluten Sensitivity

Wheat Sensitivity

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

The aim of this randomized, double-blind, placebo-controlled clinical trial is to investigate the effects of probiotics on symptoms and gut microbiota composition following gluten reintroduction. The...

Detailed Description

Non-Celiac Gluten Sensitivity (NCGS), or Non-Celiac Wheat Sensitivity (NCWS), is a condition characterized by the onset of gastrointestinal and systemic symptoms following the consumption of gluten-co...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • age≥18 years
  • NCGWS demonstrated by the following self-reported conditions i) intestinal and extra intestinal symptoms associated within hours or days after the ingestion of gluten-containing food, ii) a clear benefit while on a gluten-free diet, iii) relapse of symptoms with the ingestion of gluten-containing foods, iv) a positive response to the double-blind placebo-controlled (DBPC) cross-over gluten challenge test, as previously described.
  • Exclusion criteria:
  • presence of Crohn disease (CD), wheat allergy (WA), irritable bowel syndrome (IBS), and other gastrointestinal diseases, H. Pylori infection, lactose intolerance, history of gastrointestinal surgery, liver/pancreatic diseases, active or recent infection diseases, known psychiatric diseases, any systemic diseases
  • pregnancy or breastfeeding
  • active use of antibiotics, pre-probiotics, immunosuppressive drugs, non-steroidal anti-inflammatory drugs, or corticosteroids,
  • inability to give written informed consent.

Exclusion

    Key Trial Info

    Start Date :

    September 10 2018

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    January 10 2025

    Estimated Enrollment :

    30 Patients enrolled

    Trial Details

    Trial ID

    NCT06884241

    Start Date

    September 10 2018

    End Date

    January 10 2025

    Last Update

    March 19 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    AOU Città della Salute e della Scienza di Torino, University of Torino

    Torino, Italy, 10126